JYHZ2100750 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs(5.1) | License Renew | 2021-12-31 | | | | | view |
JYHZ2100749 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs(5.1) | License Renew | 2021-12-31 | | | | | view |
JYHB2400549 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2024-10-15 | | | | | view |
JYHB2400548 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2024-10-15 | | | | | view |
JYHB2400482 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2024-09-04 | | | | | view |
JYHB2400481 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2024-09-04 | | | | | view |
JYHB2200573 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2022-10-25 | | | | | view |
JYHB2200572 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2022-10-25 | | | | | view |
JYHB2100109 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2021-01-30 | | | Certificate Issued | 2021-03-08 | view |
JYHB2100108 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2021-01-30 | | | Certificate Issued | 2021-03-08 | view |
JYHB1901348 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2019-11-06 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Filed | 2019-11-21 | view |
JYHB1901347 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2019-11-06 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Filed | 2019-11-21 | view |
JYHB1801430 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2018-12-17 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2019-02-26 | view |
JYHB1801429 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2018-12-17 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2019-02-26 | view |
JYHB1801222 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2018-10-15 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Filed | 2018-10-22 | view |
JYHB1801221 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2018-10-15 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Filed | 2018-10-22 | view |
JYHB1800991 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2018-08-17 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Filed | 2018-08-22 | view |
JYHB1800990 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2018-08-17 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Filed | 2018-08-22 | view |
JYHB1800570 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2018-05-16 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2018-06-29 | view |
JYHB1800569 | 乙磺酸尼达尼布软胶囊 | nintedanib esylate | Soft capsules | Chemical Drugs | Supplementary Application | 2018-05-16 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2018-06-29 | view |